<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2020v4.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2022-03-25T18:30:15-05:00</ReturnTs>
    <TaxPeriodEndDt>2021-05-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>371611326</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>ARONSON LLC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>111 ROCKVILLE PIKE SUITE 600</AddressLine1Txt>
        <CityNm>ROCKVILLE</CityNm>
        <StateAbbreviationCd>MD</StateAbbreviationCd>
        <ZIPCd>20850</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2020-06-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>237033369</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION FDTN</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>AMER</BusinessNameControlTxt>
      <PhoneNum>3016648612</PhoneNum>
      <USAddress>
        <AddressLine1Txt>4500 EAST-WEST HIGHWAY 900</AddressLine1Txt>
        <CityNm>Bethesda</CityNm>
        <StateAbbreviationCd>MD</StateAbbreviationCd>
        <ZIPCd>20814</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>STEVEN RUBLOFF</PersonNm>
      <PersonTitleTxt>SECRETARY AND CEO</PersonTitleTxt>
      <SignatureDt>2022-03-25</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <SigningOfficerGrp>
      <PersonFullName>
        <PersonFirstNm>STEVEN</PersonFirstNm>
        <PersonLastNm>RUBLOFF</PersonLastNm>
      </PersonFullName>
      <SSN>999009999</SSN>
    </SigningOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>GREGORY M PLOTTS CPA</PreparerPersonNm>
      <PTIN>P01255941</PTIN>
      <PhoneNum>3012316200</PhoneNum>
    </PreparerPersonGrp>
    <TaxYr>2020</TaxYr>
    <BuildTS>2022-09-23 18:48:47Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="8">
    <IRS990 documentId="IRS990" softwareId="20011424" softwareVersionNum="2020v4.0">
      <DoingBusinessAsName>
        <BusinessNameLine1Txt>ASHP FOUNDATION</BusinessNameLine1Txt>
      </DoingBusinessAsName>
      <PrincipalOfcrBusinessName>
        <BusinessNameLine1Txt>STEVEN RUBLOFF</BusinessNameLine1Txt>
      </PrincipalOfcrBusinessName>
      <USAddress>
        <AddressLine1Txt>4500 EAST-WEST HIGHWAY 900</AddressLine1Txt>
        <CityNm>Bethesda</CityNm>
        <StateAbbreviationCd>MD</StateAbbreviationCd>
        <ZIPCd>20814</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>5497774</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>www.ashpfoundation.org</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1968</FormationYr>
      <LegalDomicileStateCd>MD</LegalDomicileStateCd>
      <ActivityOrMissionDesc>The mission of the ASHP Foundation is to support ASHP by advancing the professional practice of pharmacists and the pharmacy workforce by funding research and education that improves health outcomes through optimal, safe and effective medication use.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>14</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>11</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <TotalVolunteersCnt>100</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>928082</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>2768012</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>1118585</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>1113342</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>325684</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>1032723</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>0</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>0</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>2372351</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>4914077</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>432880</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>431305</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>1503470</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>1529410</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>626761</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>649631</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>655666</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>2585981</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>2616381</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-213630</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>2297696</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>9865167</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>13642380</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>864752</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>691055</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>9000415</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>12951325</NetAssetsOrFundBalancesEOYAmt>
      <MissionDesc>OUR MISSION:SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE AND EFFECTIVE MEDICATION USE.OUR VISION:AS THE PHILANTHROPIC ARM OF ASHP, THE FOUNDATION SHARES ASHP'S VISION THAT MEDICATION USE WILL BE OPTIMAL, SAFE, AND EFFECTIVE FOR ALL PEOPLE ALL OF THE TIME.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>841186</ExpenseAmt>
      <GrantAmt>158575</GrantAmt>
      <RevenueAmt>525590</RevenueAmt>
      <Desc>Excellence In Pharmacy Practice &amp; Leadership Development: Recognize and promote efforts that foster Excellence and growth of health-system pharmacy. ASHP Student Leadership Award This program, funded through the David A. Zilz Fund, is administered by the ASHP Pharmacy Student Forum in collaboration with the ASHP Foundation. Nine students who demonstrate high academic achievement, exceptional interest in health-system pharmacy practice, and outstanding leadership skills were recognized. The awardees received a plaque, a $2,000 award and an ASHP drug information library. Each awardee submitted a plan to raise student awareness of the ASHP Practice Advancement Initiative. Awardees will be surveyed to collect information on implementation and outcomes of their plan. Pharmacy Residency Excellence Awards Program The 2020 Pharmacy Residency Excellence Awards Program was supported by Amgen, Inc and Samson Medical Technologies. This unique award recognizes excellence and leadership in the training and mentoring of pharmacy residents. The Pharmacy Residency Excellence Awards Program recognizes a preceptor, new preceptor and program. The objectives of this program are to: 1) recognize the achievements of residency programs and pharmacists who have demonstrated excellence and leadership in the training of pharmacy residents and 2) widely disseminate the results of these accomplishments to foster innovations in pharmacy resident training. Each awardee will also present an educational webinar on a resident professional development topic that continuing education credits. The webinars are recorded and made available for on-demand access. Literature Awards Program - The ASHP Foundation Literature Awards program recognizes important contributions to the biomedical literature by pharmacists. This program, administered by the ASHP Foundation since 1971, is based on the concept that recognition through awards stimulates research and innovation and fosters improvement in the quality of the evidence. Awardees are recognized at the ASHP Midyear Clinical Meeting. Traineeships In FY21, the Foundation administered the experiential education for one traineeship. Pain and Palliative Care Traineeship The Pain and Palliative Care Traineeship included access to the ASHP Pain Management Certificate and live case-based webinars, an experiential training component, and a post-traineeship project component, which was supported through participant tuition in FY20. Due to COVID19, experiential training for all participants was postponed. Two pharmacists completed their experiential training in FY21. One completed it with The University of Iowa Hospitals and Clinics and one completed it with Southern Illinois University - Edwardsville. Pharmacy Residency Expansion Grant In FY21, the ASHP Foundation, supported by an educational donation from Merck, awarded $100,000 dollars in grants to PGY-1 and PGY-2 pharmacy residency programs to increase the number of available training positions. There were 3 grants awarded. Pharmacy Student Clinical Skills Competition Melanie Umbaugh &amp; Morgan Ostinowsky, University of Pittsburgh School of Pharmacy competed in a virtual competition for the 2020 ASHP National Clinical Skills CompetitionSM, and were awarded in December 2020, during the ASHP Midyear Clinical Meeting (virtual). The Foundation has sponsored the Pharmacy Student Clinical Skills Competition (CSC) at the ASHP Midyear Clinical Meeting 15 years. Teams who won preliminary competitions at their local pharmacy school participated in the competition. During the CSC, students demonstrate their skills by assessing patient information and current therapy, identifying and prioritizing drug therapy problems, identifying treatment goals, and recommending a pharmacist care plan. Medication Safety Scholars ASHP Foundation in partnership with Emily Jerry Foundation and the ASHP Student Forum selected participants for the Medication Safety Scholars program. The program is a distance impact program structured to support five P2 and P3 Doctor of Pharmacy students, paired with one group coach, to enhance their knowledge and skills in medication safety. Thirty applications were received and reviewed by volunteers from the ASHP Medication Safety Section Advisory Group. 503b Outsourcing Assessment Tool The ASHP Foundation provided funding to ASHP to update the 503b outsourcing assessment tool which will be available to ASHP members and practitioners. Specialty Pharmacy State of Practice in Hospitals and Health-Systems New Directions Summit The ASHP Foundation provided funding to ASHP to support the ASHP Specialty Pharmacy State of Practice in Hospital and Health-Systems New Directions Summit. The inter-professional summit featured focused discussions and recommendations on key areas in specialty pharmacy medication management, including addressing market trends, shift in the payer market, partnerships with manufacturers, emerging specializations from accreditors, and the impact on affordability, accessibility, and outcomes related to specialty pharmacy and patient care. Harvey A. K. Whitney Award Lectures Online Collection Program The Harvey A.K. Whitney Award is the most prestigious award in health-system pharmacy. The Whitney Award Lectures Online Collection Program includes a website for dissemination of Whitney lectures. The website provides access to more than 60 lectures that can be browsed by title, author, publication date or keyword. These lectures represent more than 50 years of excellence in pharmacy practice, providing a unique glimpse into our collective past, a commentary on the present, and an outline of the challenges and opportunities that lie ahead. In May 2021, administration of the website transitioned over to ASHP from the ASHP Foundation. Visiting Leaders Program (VLP) The Visiting Leaders program, with support from the David A. Zilz Leaders for the Future Fund, had another successful year. Ten leaders were involved in 16 residency visits, reaching residents, in 16 states in FY21. Due to COVID-19, all visits were conducted as a one-day virtual session. Pharmacy Leadership Academy (PLA) The PLA, supported in part by a grant from Apexus, is an online education program designed to provide comprehensive leadership education to pharmacists and pharmacy technicians. The PLA class in FY21 consisted of 86 participants, who also remitted tuition and were enrolled in the program from July 2020 - June 2021. The number of graduates from this class brings the total number of PLA graduates to 945 pharmacists. Student Leadership Development Workshop The 3-hour Leadership Development Workshop for pharmacy students is conducted annually at the ASHP Summer Meetings. State affiliates have taken advantage of the program to engage students at their annual meetings. No workshops were scheduled in FY21. William A. Zellmer Leadership Lecture: Where Practice Meets Policy This annual luncheon-lecture event, hosted by ASHP in partnership with the ASHP Foundation, is designed to honor the distinguished 40-year ASHP career of William A. Zellmer and is supported by donors to the ASHP Foundation's William Zellmer Fund. The Lecture was not awarded in FY21 due to COVID.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>693325</ExpenseAmt>
        <GrantAmt>272730</GrantAmt>
        <Desc>Innovative Research: support health services research that foster innovation in pharmacy practice, which promotes the optimal, safe and effective use of medication. Pharmacy Practice Advancement Demonstration Grant (PAI) This grant previously awarded funding up to $75,000 split into three (3) separate payments for demonstration projects related to advancing pharmacy practice and improving outcomes. The grant period for this program is 24 months with the possibility for grantees to request an extension up to one year. Tracking progress reports and final payments of previous year's recipients took place in FY21. American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowship The ASHP Foundation provided annual funding of $10,000 for the AFPE Pre-Doctoral Fellowship program. Radio Frequency Identification (RFID) Initiative In alignment with the ASHP Innovation Center and through support from Fresenius Kabi, the ASHP Foundation began a RFID research initiative to delve into practice gaps, opportunities and challenges for expanding RFID technology in healthcare. A live webinar focused on implementing RFID technology was conducted by a panel and recorded for on-demand access. A RFID Technology to Optimize Medication Use Safety survey was launched and work began on the virtual research component. Patient Medication Education In collaboration with phactMI, the Foundation conducted a survey of ASHP members to understand the role, systems and processes, resource needs related to medication education to optimize patient care and outcomes. PhactMI conducted a survey to the public to understand patient education needs and preferences. Results will be disseminated in an educational session and a manuscript. Pharmacy Leadership Scholars The ASHP Foundation launched a new research grant program with corporate support from Chiesi. The Pharmacy Leadership Scholars program is a research grant program providing funding for projects focused on DEI conducted by early-stage pharmacists. In addition to providing up to $10,000 in grant funding per recipient, the program's goal is to enhance the leadership and research skills of recipients and to provide a network of pharmacists positioned to lead for equity. The selected participants will also participate in an online impact collaborative consisting of four education modules with a focus on leadership development and DEI. Fifteen proposals were received and advanced for review by an external panel. Four faculty members and one coach collaborated with the ASHP Foundation staff on the curriculum for the modules. Collaborative Care Grant for Nurses and Pharmacists Created in partnership by the ASHP Foundation and the American Nurses Foundation, this grant program aims to stimulate patient-centered interprofessional health services research that demonstrates meaningful outcomes. The application launched in FY21 in order to select recipients of research grant funding up to $75,000. Fifteen proposals were received and advanced for review by an external panel. Pharmacy Forecast Report 2021 The 2021 Pharmacy Forecast Report was supported by a grant from Omnicell, Inc., to the ASHP Foundation's David A. Zilz Leaders for the Future Fund and was published in AJHP in the March 15, 2021 issue. The distribution of the Forecast Report in AJHP ensured that it was made available to all 58,000 ASHP members. It was published electronically in February 2021 and previewed during an educational session at the 2020 ASHP Midyear Clinical Meeting. The report generated authoritative, actionable strategic recommendations to enhance the effectiveness of leaders in hospital and health-system pharmacy. Pharmacy Resident Practice-Based Research Grant Program - A six-member external peer review panel recommended awarding 8 grants up to $5,000 each. Funding is distributed upon receipt of IRB-approval, resulting in distribution of grant funds between FY21 and FY22. New Practitioner Pharmacist Leadership Development Research Grant Program This new grant program, funded through the Marianne F. Ivey Leadership Development Fund, awards New Practitioner Pharmacists to support research on leadership competency development or to create education, resources and tools to support leadership development. An external peer review panel recommended awarding 7 grants up to $5,000 each. Funding is distributed upon receipt of IRB-approval, resulting in distribution of grant funds between FY21 and FY22. Grantees also participated in a virtual Impact Collaborative, consisting of modules that provide educational content and the opportunity to discuss the progress of their projects. Optimizing Technology Solutions Innovation Grant Seventeen full applications were reviewed by an external panel in order to award the 2020 grantees. Created in partnership with the ASHP Innovation Center and supported by a generous donation from Omnicell to the ASHP Foundation, each grantee was awarded up to $30,000. Research Advisory Council In FY21, the ASHP Foundation Board of Directors reappointed members to the Research Advisory Council to guide the focus and expansion of our research program. The Council met virtually throughout the year to review and update the research agenda framework of Core Principles and Priority Research Areas that align with the Foundation's mission and ASHP's major priorities and are at the forefront of the national healthcare agenda. The Council provided input on procedures for grants and grant tracking.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <RevenueAmt>562752</RevenueAmt>
        <Desc>THE ASHP FOUNDATION CORPORATE PARTNERS PROGRAM IS A STRATEGIC PARTNERSHIP BETWEEN THE ASHP FOUNDATION, ASHP, AND CORPORATIONS WHICH PROMOTES MEDICATION SAFETY AND IMPROVEMENTS IN PATIENT CARE. THE PROGRAM OFFERS A ROBUST MENU OF SPONSORSHIP LEVELS AND BENEFITS FOR COMPANIES, FOCUSED ON COLLABORATION, RECOGNITION, AND INFORMATIONAL OPPORTUNITIES. THERE ARE FOUR SPONSORSHIP LEVELS AND A-LA-CARTE OPPORTUNITIES TO BETTER MEET BUSINESS OBJECTIVES. CORPORATE PARTNERS PROGRAM SPONSORSHIP IS ON AN ANNUAL BASIS. WITH THE GENEROUS SUPPORT OF CORPORATE PARTNERS, THE ASHP FOUNDATION INVESTS IN RESEARCH, AWARDS, EDUCATION, AND LEADERSHIP DEVELOPMENT THAT ADVANCES THE PHARMACY PROFESSION AND ENSURES THE SAFE, EFFECTIVE, AND OPTIMAL USE OF MEDICATIONS.</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>1534511</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="IRS990ScheduleA">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="IRS990ScheduleB">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
      <ConservationEasementsInd>false</ConservationEasementsInd>
      <CollectionsOfArtInd>false</CollectionsOfArtInd>
      <CreditCounselingInd>false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="IRS990ScheduleD">true</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="IRS990ScheduleD">true</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd>false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd>false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd>false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd>false</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd>false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">true</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">true</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>false</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="IRS990ScheduleI">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="IRS990ScheduleI">true</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="IRS990ScheduleJ">true</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd referenceDocumentId="IRS990ScheduleR">true</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd referenceDocumentId="IRS990ScheduleR">true</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>59</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>true</BackupWthldComplianceInd>
      <EmployeeCnt>0</EmployeeCnt>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>false</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>14</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>11</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>true</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>false</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>true</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>MD</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>Tracy Yaklyvich</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>3016648696</PhoneNum>
        <USAddress>
          <AddressLine1Txt>4500 EAST-WEST HIGHWAY SUITE 900</AddressLine1Txt>
          <CityNm>Bethesda</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>20814</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Christene Jolowsky</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>Treasurer</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>4.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>John T Tighe III</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>Chair</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Kelly M Smith</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>Vice Chair</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>10000</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Paul W Abramowitz</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>President</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>40.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>958422</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>62625</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Steven A Rubloff</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>Secretary/ASHP Foundation CEO</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>355886</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>60010</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Chris Hatwig</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>Director At Large</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Janet Mighty</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>Director at Large</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Kathleen Pawlicki</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>Immediate Past President</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>10000</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Ken Perez</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>Director At Large</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Minnie Baylor-Henry</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>Director At Large</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Roger Anderson</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>Director At Large</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Scott M Samson</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>Director At Large</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Thomas J Johnson</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>ASHP President</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>10000</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Thomas J Rice</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>Director At Large</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>BARBARA NUSSABAUM</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>VP - RESEARCH AND EDUCATION</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>178354</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>59375</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>MARTHA CREWS</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>VP - DEVELOPMENT</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>123180</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>37110</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <BusinessName>
          <BusinessNameLine1Txt>STEPHANIE BROWN</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>DIRECTOR - FOUNDATION OPERATIONS</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>118169</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>25589</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>775589</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>988422</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>244709</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>4</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>true</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <CntrctRcvdGreaterThan100KCnt>0</CntrctRcvdGreaterThan100KCnt>
      <RelatedOrganizationsAmt>358750</RelatedOrganizationsAmt>
      <AllOtherContributionsAmt>2409262</AllOtherContributionsAmt>
      <TotalContributionsAmt>2768012</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>PHARMACY LEADERSHIP ACADEMY</Desc>
        <BusinessCd>611430</BusinessCd>
        <TotalRevenueColumnAmt>520590</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>520590</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>CORPORATE PARTNER PROGRAM</Desc>
        <BusinessCd>611430</BusinessCd>
        <TotalRevenueColumnAmt>562752</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>562752</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>SPONSORSHIPS</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>25000</TotalRevenueColumnAmt>
        <ExclusionAmt>25000</ExclusionAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>PAIN &amp; PALLIATIVE TRAINING</Desc>
        <BusinessCd>611430</BusinessCd>
        <TotalRevenueColumnAmt>5000</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>5000</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalOthProgramServiceRevGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>0</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>0</ExclusionAmt>
      </TotalOthProgramServiceRevGrp>
      <TotalProgramServiceRevenueAmt>1113342</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>338642</TotalRevenueColumnAmt>
        <ExclusionAmt>338642</ExclusionAmt>
      </InvestmentIncomeGrp>
      <RentalIncomeOrLossGrp>
        <RealAmt>0</RealAmt>
        <PersonalAmt>0</PersonalAmt>
      </RentalIncomeOrLossGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>1277778</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>583697</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>694081</SecuritiesAmt>
        <OtherAmt>0</OtherAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>694081</TotalRevenueColumnAmt>
        <ExclusionAmt>694081</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <MiscellaneousRevenueGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>0</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>0</ExclusionAmt>
      </MiscellaneousRevenueGrp>
      <OtherRevenueTotalAmt>0</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>4914077</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1088342</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>1057723</ExclusionAmt>
      </TotalRevenueGrp>
      <InfoInScheduleOPartIXInd>X</InfoInScheduleOPartIXInd>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>394092</TotalAmt>
        <ProgramServicesAmt>394092</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>37213</TotalAmt>
        <ProgramServicesAmt>37213</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>415896</TotalAmt>
        <ProgramServicesAmt>189565</ProgramServicesAmt>
        <ManagementAndGeneralAmt>65154</ManagementAndGeneralAmt>
        <FundraisingAmt>161177</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>841052</TotalAmt>
        <ProgramServicesAmt>383352</ProgramServicesAmt>
        <ManagementAndGeneralAmt>131758</ManagementAndGeneralAmt>
        <FundraisingAmt>325942</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>99975</TotalAmt>
        <ProgramServicesAmt>45569</ProgramServicesAmt>
        <ManagementAndGeneralAmt>15662</ManagementAndGeneralAmt>
        <FundraisingAmt>38744</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>99832</TotalAmt>
        <ProgramServicesAmt>45504</ProgramServicesAmt>
        <ManagementAndGeneralAmt>15639</ManagementAndGeneralAmt>
        <FundraisingAmt>38689</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>72655</TotalAmt>
        <ProgramServicesAmt>33116</ProgramServicesAmt>
        <ManagementAndGeneralAmt>11382</ManagementAndGeneralAmt>
        <FundraisingAmt>28157</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>12870</TotalAmt>
        <ManagementAndGeneralAmt>12870</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>51127</TotalAmt>
        <ManagementAndGeneralAmt>51127</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>394868</TotalAmt>
        <ProgramServicesAmt>298364</ProgramServicesAmt>
        <ManagementAndGeneralAmt>85407</ManagementAndGeneralAmt>
        <FundraisingAmt>11097</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>0</TotalAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>68393</TotalAmt>
        <ProgramServicesAmt>54894</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4034</ManagementAndGeneralAmt>
        <FundraisingAmt>9465</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>2970</TotalAmt>
        <ManagementAndGeneralAmt>2970</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <TravelGrp>
        <TotalAmt>24506</TotalAmt>
        <ProgramServicesAmt>10340</ProgramServicesAmt>
        <ManagementAndGeneralAmt>676</ManagementAndGeneralAmt>
        <FundraisingAmt>13490</FundraisingAmt>
      </TravelGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>44432</TotalAmt>
        <ManagementAndGeneralAmt>44432</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <OtherExpensesGrp>
        <Desc>credit card fees</Desc>
        <TotalAmt>9978</TotalAmt>
        <ManagementAndGeneralAmt>9978</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Honoraria</Desc>
        <TotalAmt>5000</TotalAmt>
        <ProgramServicesAmt>5000</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Preceptor Fees</Desc>
        <TotalAmt>37500</TotalAmt>
        <ProgramServicesAmt>37500</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Charitable annuity</Desc>
        <TotalAmt>4022</TotalAmt>
        <ManagementAndGeneralAmt>4022</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>0</TotalAmt>
        <ProgramServicesAmt>0</ProgramServicesAmt>
        <ManagementAndGeneralAmt>0</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>2616381</TotalAmt>
        <ProgramServicesAmt>1534509</ProgramServicesAmt>
        <ManagementAndGeneralAmt>455111</ManagementAndGeneralAmt>
        <FundraisingAmt>626761</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>160544</BOYAmt>
        <EOYAmt>264584</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>21418</BOYAmt>
        <EOYAmt>460822</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>401165</BOYAmt>
        <EOYAmt>1318997</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <EOYAmt>72917</EOYAmt>
      </AccountsReceivableGrp>
      <ReceivablesFromOfficersEtcGrp>
        <EOYAmt>0</EOYAmt>
      </ReceivablesFromOfficersEtcGrp>
      <RcvblFromDisqualifiedPrsnGrp>
        <EOYAmt>0</EOYAmt>
      </RcvblFromDisqualifiedPrsnGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>40644</BOYAmt>
        <EOYAmt>68366</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>283347</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>141514</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>186266</BOYAmt>
        <EOYAmt>141833</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>8914470</BOYAmt>
        <EOYAmt>11144108</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <InvestmentsOtherSecuritiesGrp>
        <BOYAmt>125642</BOYAmt>
        <EOYAmt>147234</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <InvestmentsProgramRelatedGrp>
        <BOYAmt>0</BOYAmt>
      </InvestmentsProgramRelatedGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>15018</BOYAmt>
        <EOYAmt>23519</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>9865167</BOYAmt>
        <EOYAmt>13642380</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>307673</BOYAmt>
        <EOYAmt>180805</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <DeferredRevenueGrp>
        <BOYAmt>557079</BOYAmt>
        <EOYAmt>510250</EOYAmt>
      </DeferredRevenueGrp>
      <LoansFromOfficersDirectorsGrp>
        <EOYAmt>0</EOYAmt>
      </LoansFromOfficersDirectorsGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>864752</BOYAmt>
        <EOYAmt>691055</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>1506384</BOYAmt>
        <EOYAmt>3192823</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>7494031</BOYAmt>
        <EOYAmt>9758502</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>9000415</BOYAmt>
        <EOYAmt>12951325</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>9865167</BOYAmt>
        <EOYAmt>13642380</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>2297696</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>1653214</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <ConsolAndSepBasisFinclStmtInd>X</ConsolAndSepBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="IRS990ScheduleA" softwareId="20011424" softwareVersionNum="2020v4.0">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>1799986</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>2088349</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1768602</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>928082</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>2768012</CurrentTaxYearAmt>
        <TotalAmt>9353031</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TaxRevLeviedOrgnztnlBnft170Grp>
        <TotalAmt>0</TotalAmt>
      </TaxRevLeviedOrgnztnlBnft170Grp>
      <GovtFurnSrvcFcltsVl170Grp>
        <TotalAmt>0</TotalAmt>
      </GovtFurnSrvcFcltsVl170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>1799986</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>2088349</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1768602</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>928082</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>2768012</CurrentTaxYearAmt>
        <TotalAmt>9353031</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>4464931</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>4888100</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>270016</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>315175</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>406338</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>303024</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>338642</CurrentTaxYearAmt>
        <TotalAmt>1633195</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <UnrelatedBusinessNetIncm170Grp>
        <TotalAmt>0</TotalAmt>
      </UnrelatedBusinessNetIncm170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>0</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>0</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>0</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>0</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>0</CurrentTaxYearAmt>
        <TotalAmt>0</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>10986226</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>4066202</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.4449</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.459</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="IRS990ScheduleB" softwareId="20011424" softwareVersionNum="2020v4.0">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="IRS990ScheduleD" softwareId="20011424" softwareVersionNum="2020v4.0">
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>6731177</BeginningYearBalanceAmt>
        <ContributionsAmt>2650</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>2218348</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>1276916</OtherExpendituresAmt>
        <EndYearBalanceAmt>7675259</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>6808429</BeginningYearBalanceAmt>
        <ContributionsAmt>1300</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>106680</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>185232</OtherExpendituresAmt>
        <EndYearBalanceAmt>6731177</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>6838821</BeginningYearBalanceAmt>
        <ContributionsAmt>1480</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>93478</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>125350</OtherExpendituresAmt>
        <EndYearBalanceAmt>6808429</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>6732965</BeginningYearBalanceAmt>
        <ContributionsAmt>6019</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>423554</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>323717</OtherExpendituresAmt>
        <EndYearBalanceAmt>6838821</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>6264149</BeginningYearBalanceAmt>
        <ContributionsAmt>291302</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>654392</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>476878</OtherExpendituresAmt>
        <EndYearBalanceAmt>6732965</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <BoardDesignatedBalanceEOYPct>0.0651</BoardDesignatedBalanceEOYPct>
      <PrmnntEndowmentBalanceEOYPct>0.6639</PrmnntEndowmentBalanceEOYPct>
      <TermEndowmentBalanceEOYPct>0.271</TermEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>false</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>false</EndowmentsHeldRelatedOrgInd>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>83984</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>81705</DepreciationAmt>
        <BookValueAmt>2279</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>199363</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>59809</DepreciationAmt>
        <BookValueAmt>139554</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>141833</TotalBookValueLandBuildingsAmt>
      <TotalRevEtcAuditedFinclStmtAmt>6752822</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>1653214</NetUnrealizedGainsInvstAmt>
      <DonatedServicesAndUseFcltsAmt>236658</DonatedServicesAndUseFcltsAmt>
      <OtherRevenueAmt>0</OtherRevenueAmt>
      <RevenueNotReportedAmt>1889872</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>4862950</RevenueSubtotalAmt>
      <InvestmentExpensesNotIncldAmt>51127</InvestmentExpensesNotIncldAmt>
      <OtherRevenuesNotIncludedAmt>0</OtherRevenuesNotIncludedAmt>
      <RevenueNotReportedFinclStmtAmt>51127</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>4914077</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>2801912</TotExpnsEtcAuditedFinclStmtAmt>
      <DonatedServicesUseFcltsAmt>236658</DonatedServicesUseFcltsAmt>
      <OtherExpensesIncludedAmt>0</OtherExpensesIncludedAmt>
      <ExpensesNotReportedAmt>236658</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>2565254</ExpensesSubtotalAmt>
      <InvestmentExpensesNotIncld2Amt>51127</InvestmentExpensesNotIncld2Amt>
      <OtherExpensesNotIncludedAmt>0</OtherExpensesNotIncludedAmt>
      <ExpensesNotRptFinclStmtAmt>51127</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>2616381</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule D, Part V, Line 4 Intended uses of endowment funds</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH IS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleI documentId="IRS990ScheduleI" softwareId="20011424" softwareVersionNum="2020v4.0">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>American Foundation for Pharmaceutical Education</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>11325 Random Hills Road</AddressLine1Txt>
          <CityNm>Fairfax</CityNm>
          <StateAbbreviationCd>VA</StateAbbreviationCd>
          <ZIPCd>22030</ZIPCd>
        </USAddress>
        <RecipientEIN>530214882</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>10000</CashGrantAmt>
        <PurposeOfGrantTxt>The grant purpose was 2020 Sponsorship</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>American Society of Health-System Pharmacists</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>4500 East-West Highway</AddressLine1Txt>
          <CityNm>Bethesda</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>20814</ZIPCd>
        </USAddress>
        <RecipientEIN>520807628</RecipientEIN>
        <IRCSectionDesc>501(C)6</IRCSectionDesc>
        <CashGrantAmt>181362</CashGrantAmt>
        <PurposeOfGrantTxt>Clinical Skills Competition, 503B Outsourcing Tool Update, Specialty Pharmacy Summit</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Ascension Genesys Foundation</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>One Genesys Parkway</AddressLine1Txt>
          <CityNm>Grand Blanc</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>48439</ZIPCd>
        </USAddress>
        <RecipientEIN>383591148</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>25000</CashGrantAmt>
        <PurposeOfGrantTxt>The grant purpose was a Resident Expansion Grant</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Kaiser Foundation Health Plan of Colorado</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>2500 South Havana Street</AddressLine1Txt>
          <CityNm>Aurora</CityNm>
          <StateAbbreviationCd>CO</StateAbbreviationCd>
          <ZIPCd>80014</ZIPCd>
        </USAddress>
        <RecipientEIN>840591617</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>30000</CashGrantAmt>
        <PurposeOfGrantTxt>Technology Innovation Grant</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>The St Jude Children's Research Hospital Inc</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>262 Danny Thomas Place</AddressLine1Txt>
          <CityNm>Memphis</CityNm>
          <StateAbbreviationCd>TN</StateAbbreviationCd>
          <ZIPCd>381053678</ZIPCd>
        </USAddress>
        <RecipientEIN>620646012</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>25000</CashGrantAmt>
        <PurposeOfGrantTxt>The grant purpose was a Resident Expansion Grant</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University of Chicago Medical Center</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>5841 South Maryland Avenue</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60637</ZIPCd>
        </USAddress>
        <RecipientEIN>363488183</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>25000</CashGrantAmt>
        <PurposeOfGrantTxt>The grant purpose was a Resident Expansion Grant</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University of North Carolina at Chapel Hill</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>PO Box 402420</AddressLine1Txt>
          <CityNm>Atlanta</CityNm>
          <StateAbbreviationCd>GA</StateAbbreviationCd>
          <ZIPCd>303842420</ZIPCd>
        </USAddress>
        <RecipientEIN>566001393</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>26777</CashGrantAmt>
        <PurposeOfGrantTxt>Optimizing Technology Innovation Grant</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University of Tennessee</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>201 Andy Holt Tower</AddressLine1Txt>
          <CityNm>Knoxville</CityNm>
          <StateAbbreviationCd>TN</StateAbbreviationCd>
          <ZIPCd>379960100</ZIPCd>
        </USAddress>
        <RecipientEIN>626001636</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>25500</CashGrantAmt>
        <PurposeOfGrantTxt>Practice Advancement Grant</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>7</Total501c3OrgCnt>
      <TotalOtherOrgCnt>1</TotalOtherOrgCnt>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>Literature Awards</GrantTypeTxt>
        <RecipientCnt>4</RecipientCnt>
        <CashGrantAmt>13213</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>Student Leadership Awards</GrantTypeTxt>
        <RecipientCnt>12</RecipientCnt>
        <CashGrantAmt>24000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds.</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED, WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. ANY UNUSED GRANT FUNDS MUST BE RETURNED. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="IRS990ScheduleJ" softwareId="20011424" softwareVersionNum="2020v4.0">
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <Form990OfOtherOrganizationsInd>X</Form990OfOtherOrganizationsInd>
      <WrittenEmploymentContractInd>X</WrittenEmploymentContractInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>false</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>false</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>false</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>false</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>false</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>true</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>true</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>true</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>false</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Steven A Rubloff</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>Secretary/ASHP Foundation CEO</TitleTxt>
        <BaseCompensationFilingOrgAmt>328564</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>25000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>2322</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>21284</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>38726</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>415896</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <BusinessName>
          <BusinessNameLine1Txt>Paul W Abramowitz</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>President</TitleTxt>
        <BaseCompensationFilingOrgAmt>0</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>807843</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>121500</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>29079</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>0</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>28200</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>0</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>34425</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>0</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>1021047</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <BusinessName>
          <BusinessNameLine1Txt>BARBARA NUSSABAUM</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>VP - RESEARCH AND EDUCATION</TitleTxt>
        <BaseCompensationFilingOrgAmt>175557</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>1000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>1797</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>19001</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>40374</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>237729</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <BusinessName>
          <BusinessNameLine1Txt>MARTHA CREWS</BusinessNameLine1Txt>
        </BusinessName>
        <TitleTxt>VP - DEVELOPMENT</TitleTxt>
        <BaseCompensationFilingOrgAmt>121576</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>1000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>604</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>5373</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>31737</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>160290</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule J, Part I, Line 6a Compensation contingent on net earnings of the organization</FormAndLineReferenceDesc>
        <ExplanationTxt>PAUL ABRAMOWITZ, PRESIDENT/ASHP CEO, AND STEVEN RUBLOFF, SECRETARY/ASHP REF CEO, RECEIVE A BONUS BASED ON THE ACHIEVEMENT OF SPECIFIC FINANCIAL AND NON-FINANCIAL OUTCOMES FOR THEIR RESPECTIVE ORGANIZATIONS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule J, Part I, Line 6b Compensation contingent on net earnings of a related organization</FormAndLineReferenceDesc>
        <ExplanationTxt>PAUL ABRAMOWITZ, PRESIDENT/ASHP CEO, AND STEVEN RUBLOFF, SECRETARY/ASHP REF CEO, RECEIVE A BONUS BASED ON THE ACHIEVEMENT OF SPECIFIC FINANCIAL AND NON-FINANCIAL OUTCOMES FOR THEIR RESPECTIVE ORGANIZATIONS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule J, Part I, Line 7 Non-fixed payments</FormAndLineReferenceDesc>
        <ExplanationTxt>ALL ASHP-REF EMPLOYEES ARE ELIGIBLE FOR AN ANNUAL PERFORMANCE INCENTIVE PROGRAM IN ACCORDANCE WITH POLICY, AT THE DISCRETION OF THE BOARD OF DIRECTORS, BASED ON MUTUALLY AGREED UPON PREDETERMINED OBJECTIVES.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="IRS990ScheduleO" softwareId="20011424" softwareVersionNum="2020v4.0">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 7a Members or stockholders electing members of governing body</FormAndLineReferenceDesc>
        <ExplanationTxt>THREE MANDATORY MEMBERS OF THE FOUNDATION'S BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, CEO, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTHSYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND CEO SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTHSYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 8b Documentation of meetings held by committees of governing body</FormAndLineReferenceDesc>
        <ExplanationTxt>THERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 11b Review of form 990 by governing body</FormAndLineReferenceDesc>
        <ExplanationTxt>The Form 990 is reviewed by officers of ASHP and ASHP Foundation and by the Board before it is filed. Each member has the opportunity to review the Form 990.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 12c Conflict of interest policy</FormAndLineReferenceDesc>
        <ExplanationTxt>THE CONFLICT OF INTEREST POLICY WILL BE REVIEWED ANNUALLY AT THE SPRING OR FALL MEETING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 15a Process to establish compensation of top management official</FormAndLineReferenceDesc>
        <ExplanationTxt>CHIEF EXECUTIVE OFFICER: PURSUANT TO THE BYLAWS, THE BOARD OF DIRECTORS HAS THE RESPONSIBILITY FOR THE SELECTION AND HIRING OF THE CEO OF THE ORGANIZATION. ELEVEN MEMBERS OF THE BOARD ARE CONSIDERED INDEPENDENT PERSONS AND RECEIVE NO COMPENSATION FROM THE ORGANIZATION. THE BOARD REVIEWS SALARY SURVEY DATA REPORTS FOR OTHER COMPARABLE EXEMPT ORGANIZATIONS AS WELL AS DATA FOR POSITIONS WHICH HAVE SIMILAR RESPONSIBILITIES. OTHER EMPLOYEES WHO ARE EMPLOYED BY THE ORGANIZATION ARE "EMPLOYEES AT WILL". SALARIES FOR THESE INDIVIDUALS ARE DETERMINED USING RELEVANT COMPARABLE SALARY DATA. PRIOR TO FILLING A VACANT POSITION, A HIRING SUPERVISOR, IN CONJUNCTION WITH THE HUMAN RESOURCES DIVISION, RESEARCHES RELEVANT SALARY RANGES FOR THE POSITION.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 19 Required documents available to the public</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part IX, Line 11g Other Fees</FormAndLineReferenceDesc>
        <ExplanationTxt>CONTRACT SERVICES - Total Expense: 394868, Program Service Expense: 298364, Management and General Expenses: 85407, Fundraising Expenses: 11097;</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="IRS990ScheduleR" softwareId="20011424" softwareVersionNum="2020v4.0">
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP)</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>4500 EAST-WEST HIGHWAY</AddressLine1Txt>
          <AddressLine2Txt>SUITE 900</AddressLine2Txt>
          <CityNm>BETHESDA</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>20814</ZIPCd>
        </USAddress>
        <EIN>520807628</EIN>
        <PrimaryActivitiesTxt>TO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSION</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>MD</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501(c)(6)</ExemptCodeSectionTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>NA</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <ReceiptOfIntAnntsRntsRyltsInd>false</ReceiptOfIntAnntsRntsRyltsInd>
      <GiftGrntOrCapContriToOthOrgInd>true</GiftGrntOrCapContriToOthOrgInd>
      <GiftGrntCapContriFromOthOrgInd>true</GiftGrntCapContriFromOthOrgInd>
      <LoansOrGuaranteesToOtherOrgInd>false</LoansOrGuaranteesToOtherOrgInd>
      <LoansOrGuaranteesFromOthOrgInd>false</LoansOrGuaranteesFromOthOrgInd>
      <DivRelatedOrganizationInd>false</DivRelatedOrganizationInd>
      <AssetSaleToOtherOrgInd>false</AssetSaleToOtherOrgInd>
      <AssetPurchaseFromOtherOrgInd>false</AssetPurchaseFromOtherOrgInd>
      <AssetExchangeInd>false</AssetExchangeInd>
      <RentalOfFacilitiesToOthOrgInd>false</RentalOfFacilitiesToOthOrgInd>
      <RentalOfFcltsFromOthOrgInd>false</RentalOfFcltsFromOthOrgInd>
      <PerformOfServicesForOthOrgInd>false</PerformOfServicesForOthOrgInd>
      <PerformOfServicesByOtherOrgInd>false</PerformOfServicesByOtherOrgInd>
      <SharingOfFacilitiesInd>true</SharingOfFacilitiesInd>
      <PaidEmployeesSharingInd>true</PaidEmployeesSharingInd>
      <ReimbursementPaidToOtherOrgInd>true</ReimbursementPaidToOtherOrgInd>
      <ReimbursementPaidByOtherOrgInd>false</ReimbursementPaidByOtherOrgInd>
      <TransferToOtherOrgInd>false</TransferToOtherOrgInd>
      <TransferFromOtherOrgInd>true</TransferFromOtherOrgInd>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>American Society of Health-System Pharmacists</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>P</TransactionTypeTxt>
        <InvolvedAmt>1600115</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>Recorded expenses</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>American Society of Health-System Pharmacists</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>S</TransactionTypeTxt>
        <InvolvedAmt>708751</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>Cash</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>American Society of Health-System Pharmacists</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>N</TransactionTypeTxt>
        <InvolvedAmt>891364</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>Recorded expenses</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>American Society of Health-System Pharmacists</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>C</TransactionTypeTxt>
        <InvolvedAmt>358750</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>Cash</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>American Society of Health-System Pharmacists</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>O</TransactionTypeTxt>
        <InvolvedAmt>180698</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>Fair Value</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>American Society of Health-System Pharmacists</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>B</TransactionTypeTxt>
        <InvolvedAmt>181362</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>Cash</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
    </IRS990ScheduleR>
  </ReturnData>
</Return>
